- Home
- SVRA vs MUX Comparison
SVRA vs MUX Comparison
Compare SVRA & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- MUX
- Stock Information
- Founded
- SVRA N/A
- MUX 1979
- Country
- SVRA United States
- MUX Canada
- Employees
- SVRA N/A
- MUX N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- MUX Precious Metals
- Sector
- SVRA Health Care
- MUX Basic Materials
- Exchange
- SVRA Nasdaq
- MUX Nasdaq
- Market Cap
- SVRA 458.2M
- MUX 411.8M
- IPO Year
- SVRA N/A
- MUX N/A
- Fundamental
- Price
- SVRA $2.69
- MUX $7.14
- Analyst Decision
- SVRA Buy
- MUX Strong Buy
- Analyst Count
- SVRA 7
- MUX 2
- Target Price
- SVRA $9.86
- MUX $15.13
- AVG Volume (30 Days)
- SVRA 633.7K
- MUX 1.4M
- Earning Date
- SVRA 03-06-2025
- MUX 03-04-2025
- Dividend Yield
- SVRA N/A
- MUX N/A
- EPS Growth
- SVRA N/A
- MUX N/A
- EPS
- SVRA N/A
- MUX 2.07
- Revenue
- SVRA N/A
- MUX $199,634,000.00
- Revenue This Year
- SVRA N/A
- MUX $21.85
- Revenue Next Year
- SVRA N/A
- MUX $17.35
- P/E Ratio
- SVRA N/A
- MUX $3.45
- Revenue Growth
- SVRA N/A
- MUX 47.02
- 52 Week Low
- SVRA $2.59
- MUX $5.92
- 52 Week High
- SVRA $5.70
- MUX $12.50
- Technical
- Relative Strength Index (RSI)
- SVRA 40.81
- MUX 36.63
- Support Level
- SVRA $2.65
- MUX $7.32
- Resistance Level
- SVRA $2.91
- MUX $7.82
- Average True Range (ATR)
- SVRA 0.11
- MUX 0.34
- MACD
- SVRA 0.01
- MUX -0.07
- Stochastic Oscillator
- SVRA 23.08
- MUX 1.01
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.